Articles tagged with Depression
Researchers identified a mechanism of action for selective serotonin reuptake inhibitors that explains their delayed effectiveness in treating depression. The study found that SSRIs accumulate in lipid rafts and reduce levels of signal molecules, contributing to the delay in symptom reduction.
The Health-eBrain Study launches Phase II to investigate the impact of Alzheimer's caregiving on brain and behavioral health. An international cohort of caregivers will use a mobile app to assess their cognitive function over 12 weeks, tracking stress levels, sleep, mood, and self-evaluation of memory.
A study found a distinct brain-to-gut pathway where psychological symptoms begin first, while another pathway links gut symptoms to mental health. Higher anxiety and depression levels predicted IBS development within a year.
A large trial has shown that behavioral activation therapy is non-inferior to cognitive behavioral therapy in treating depression, with two-thirds of participants reporting a 50% reduction in depressive symptoms. The treatment is also cheaper and more accessible, with average intervention costs £974.81 compared to CBT's £1235.23.
A large-scale study finds Behavioral Activation (BA) to be as effective as Cognitive Behavioural Therapy (CBT) in treating depression, with a significant cost savings. BA encourages individuals to engage in meaningful activities driven by personal values, reducing depressive symptoms and improving outcomes.
Children who experience inadequate or disrupted sleep are more likely to develop depression and anxiety disorders later in life. A study funded by the NIH found that poor sleep impacts children's emotional health by altering positive emotional experiences, leading to increased negative emotions and diminished impulse control.
Scientists at Northwestern University have identified a novel target for depression treatment by manipulating HCN channels in the hippocampus. Reducing these channel's function has been shown to improve mood in mice, offering new hope for millions of patients who don't respond to existing treatments.
A new study in Biological Psychiatry reveals that inflammation of the hippocampus contributes to depressive symptoms in multiple sclerosis patients. Hippocampal immune activation was linked to more severe symptoms of depression and altered functional connections with other brain regions.
A study found that palliative care-led informational and emotional support meetings did not reduce anxiety or depression symptoms among family members of patients with chronic critical illness. However, posttraumatic stress disorder symptoms were higher in the intervention group compared to the control group.
Research at Umeå University found a link between low cortisol levels and increased risk of obesity, dyslipidaemia and metabolic syndrome in patients with recurrent depressions or bipolar disorder. Cortisol regulation is linked to worsened physical health in these patients.
A study published in Psychological Medicine identified risk factors that can predict post-traumatic stress disorder (PTSD) and major depression among emergency services workers. Early assessment can help offer targeted training to improve resilience, reducing episodes of mental illness and improving long-term health.
A study found that 24 months of treatment with antidepressant escitalopram did not improve mortality, illness, or mood in patients with chronic heart failure and depression. Depression was shown to be an independent predictor of mortality and rehospitalization in these patients.
African Americans perceive depression as a weakness inconsistent with notions of strength in the community, rather than as a health condition. The study highlights the need to consider cultural perspectives in clinical assessment and measurement of depression.
Mothers who develop postpartum depression often experience protective risk factors, but once their babies are born, they show more obsessive-compulsive symptoms. Women who had depression before becoming pregnant were more likely to experience hypersomnia and difficulty falling asleep.
A recent study found that exposure to commonly used antidepressant drugs (SSRIs) during pregnancy can affect the brain activity of newborns. The research suggests that the effects on fetal brain function should be reassessed and non-pharmacological interventions should be prioritized for treating depression and anxiety during pregnancy.
A new study from Ohio State University found that unemployed individuals who use skills commonly taught as part of cognitive therapy for depression are more likely to receive a job offer. These skills include identifying negative thoughts, countering them with positive responses, and planning enjoyable activities to improve mood.
A community-based pain management programme for patients with chronic musculoskeletal pain has improved depression and social integration. The intervention showed cost-effectiveness and a novel, brief, psychologically based group intervention directed at increasing participants' confidence.
A recent study confirms a strong association between depression symptom severity and the level of disease activity and disability in adolescent patients with juvenile inflammatory arthritis. The findings underscore the need for psychological health assessment and support to be fully integrated into their routine care.
A major international review of suicide prevention has confirmed that restricting access to lethal means and providing Gatekeeper Training can be effective. The study also highlights the importance of follow-up care for individuals who have attempted suicide.
Researchers found that approximately 39% of adults who experienced major depression can attain complete mental health, characterized by happiness, life satisfaction, and well-being. Social support was a key factor associated with this outcome, particularly having close relationships.
A blood test developed by King's College London accurately predicts which depressed patients will respond to common antidepressants. The test identifies biomarkers associated with inflammation, guiding patients towards earlier access to more assertive treatments.
A six-week online training course called GET.ON has been shown to reduce the risk of developing depression in people at increased risk. The study found that 27% of those who completed the course developed depression, compared to 41% of those who did not receive the training.
A UCL study found that the habenula, a region that responds to bad experiences, functions abnormally in people with depression. In healthy adults, this region activates when expecting aversive events, but in depressed individuals, it decreases activation. The study suggests the theory on the habenula's role in depression needs rethinking.
A Norwegian study found workaholics scored higher on psychiatric symptoms than non-workaholics, with 32.7% meeting ADHD criteria and 25.6% having OCD. The research highlights the need for further investigation into neurobiological deviations related to workaholic behavior.
A study by Duke University scientists reveals a biological pathway for depression in adolescents from socioeconomically disadvantaged families. The research shows that these individuals accumulate epigenetic tags on a gene linked to depression, leading to increased amygdala activity and higher risk of depression symptoms.
A study analyzed treatment indications for antidepressants, finding that antidepressant use in the US has increased over the last two decades, with a significant portion prescribed off-label for conditions like insomnia and pain. The research highlights the need to evaluate evidence supporting off-label antidepressant use.
Teenagers who experienced childhood family adversity are more likely to be bullied at school and develop depressive symptoms. However, supportive family or friends in early adolescence can help reduce depressive symptoms later on.
Researchers discover that depression results from deficiencies in both GABA and glutamate signaling, which can be restored with a single dose of ketamine. The study uses a mouse model to develop safer alternatives to current antidepressant medications.
A small feasibility trial involving 12 people with treatment-resistant depression found that psilocybin was safe and well-tolerated, reducing symptoms of depression in about half of the participants at 3 months post-treatment. Further research is needed to understand the therapeutic benefits of psilocybin.
People with major depressive disorder may have altered purine metabolism, with higher levels of xanthine and lower inosine and guanosine. This dysregulation may be the body's compensatory mechanism to combat increased oxidative stress caused by depression.
A new study has found a significant association between prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and lower birth weight. Infants exposed to SSRIs for two or more trimesters weighed 205 grams less than those not exposed, on average.
A Canadian study reveals ICU caregivers are at high risk of developing clinical depression and emotional distress after patient discharge. The study highlights the need to consider mental health in post-ICU care, finding that caregiver characteristics and situation play a significant role in determining outcomes.
The offspring of depressed parents have a higher risk for depression, morbidity, and mortality that persists into middle age. Children with a family history are more likely to experience recurrent episodes of depression as they mature.
A new study found that parental depression is linked to increased brain activity in areas responsible for risk taking in adolescent children, leading to more rule-breaking behaviors. The study suggests that even mild depressive symptoms in parents can influence teens' behavior through changes in the brain's response to rewards.
A study by Massachusetts General Hospital found that repeat ketamine infusions decreased and, for some, eliminated suicidal thoughts in outpatients with treatment-resistant depression. Seven participants achieved complete remission of suicidal thoughts, and two maintained remission throughout the follow-up period.
According to a research review, postpartum depression affects 14.5% of women during pregnancy or after delivery, with many cases going undiagnosed and untreated. Screening tools, such as the Edinburgh Postnatal Depression Scale, can be used in various settings to identify PPD, which requires close attention from psychiatrists.
Research on neural network interactions and related brain activity patterns provides insights into thought processes that make people vulnerable to depression. The study identifies increased activity in one important brain network, called the default mode network, which may contribute to maladaptive rumination.
A study found that mothers with depression are not physiologically synchronized with their kids, even during positive interactions. The researchers measured heart rate variability and found that depressed moms missed matching their children's physiology, leading to a mismatch in social engagement.
A team of researchers has identified a ketamine metabolite that quickly reverses depression in mice without ketamine's major side effects. The study suggests that this compound may work by activating AMPA receptors, potentially opening up new vistas for the development of safer antidepressant treatments.
A new study provides first-person perspectives from African-American and Latina mothers on their experiences with postpartum depression, revealing that conventional treatments often provide little relief. The research highlights the need for concrete services like transportation and flexible work environments to manage depression effec...
Researchers found that yoga and aquatic exercise significantly improved symptoms of multiple sclerosis, including reduced fatigue, depression, and paresthesia. The study, involving 54 women with MS, showed a significant reduction in moderate to severe depression in those who exercised three times a week.
A national survey of over 34,000 adults found that individuals with bipolar disorder are equally likely to develop anxiety as depression after experiencing an episode of mania. This study may lead to a broader clinical definition of bipolar disorder that includes episodes of mania along with anxiety or depression.
A web-based guided self-help intervention has been shown to reduce the incidence of major depressive disorder in adults with subthreshold depression. The study found that 55 participants in the intervention group experienced MDD compared to 84 in the control group, resulting in a significant reduction in risk.
A long-term study of 3325 adults aged 55 and over found that depression symptoms that steadily increase in older age are more strongly linked to dementia than any other types of depression. The study suggests that increasing depressive symptoms may indicate the early stages of dementia.
Research found that children exposed to selective serotonin reuptake inhibitors (SSRIs) during gestation had a cumulative incidence of 8.2% of depression by age 15, compared to 1.9% for those without antidepressant use. The study also showed no significant difference in anxiety or ASD diagnoses.
A meta-analysis of nine published randomized trials found that mindfulness-based cognitive therapy (MBCT) was associated with a reduced risk of depressive relapse/recurrence over 60 weeks. The treatment effect appeared to be larger in patients with higher levels of depression symptoms at baseline.
A meta-analysis of nine randomized trials found that Mindfulness-Based Cognitive Therapy (MBCT) is an effective treatment option for preventing major depression relapse. Participants who received MBCT had a 31% lower risk of relapse compared to those who did not receive the therapy.
A meta-analysis of 40 clinical trials found that combining omega-3 fish oils with antidepressants had a statistically significant effect on improving mood. Other supplements like methylfolate, Vitamin D, and SAMe also showed promise as mood-enhancing therapies when taken with antidepressants.
A five-year study found that patients with negative beliefs about their diabetic foot ulcers had a higher risk of death. The study, published in PLOS ONE, suggests that addressing these attitudes could improve survival rates for people with diabetic foot ulcers.
A new study found that electronic health records (EHRs) frequently fail to capture comprehensive mental health data, resulting in potential medication errors and patient harm. The research highlights the importance of supplementing EHR-derived data with external sources to improve patient care.
A study of nearly 700 ICU survivors found that two-thirds experienced depression, anxiety, or PTSD, with most experiencing multiple symptoms. The risk factors were not related to illness severity or length of stay, but rather age, gender, unemployment, and substance misuse.
A 2-year study found that bupropion (Wellbutrin) is the only antidepressant to induce modest weight loss, while others lead to varying degrees of weight gain. Nonsmokers on bupropion lost an average of 2.4 pounds, compared to a 4.6-pound gain on fluoxetine.
Researchers found three genetic variants associated with subjective wellbeing, two with depressive symptoms, and 11 with neuroticism. The study suggests that these traits are influenced by the same set of genes and may be studied jointly in future work.
A recent study by Dr. Barbro Kjellström found that heart attack patients are more likely to be depressed, with 14% experiencing symptoms compared to 7% of control group members. However, antidepressants were prescribed less frequently among heart attack patients with depression, at just 16%, compared to 42% of control group members.
A recent study found that gang membership is associated with increased levels of depression and suicidal thoughts among middle- and high-school students. The research, conducted by Michigan State University and Bowling Green State University, highlights the negative impact of gang involvement on mental health outcomes.
Researchers found that depression combined with metabolic risk factors significantly increases the risk of developing type 2 diabetes. The study suggests a vicious cycle where depression and metabolic symptoms exacerbate each other, making integrated treatment crucial for prevention.
A new study finds a significant association between androgen deprivation therapy and depression in patients with localized prostate cancer. Patients treated with hormone therapy experienced higher incidences of depression, with risks increasing with treatment duration.
Researchers at Oregon Health & Science University have discovered the precise structure of the serotonin transporter, a key player in regulating mood and behavior. This breakthrough provides a platform for designing new, more effective small molecule therapeutics to treat depression and anxiety.
A recent study published in Frontiers in Neural Circuits identified specific brain areas that may contribute to stress-induced depression. The research found that mice displaying 'helpless' behavior had reduced neuronal activation and stereotypical brain-wide activity patterns, which are distinct from those showing 'resilient' behavior.
A Northwestern University study shows that engaging environment can alleviate depression in genetically depressed rats, suggesting that nurture can override nature. The study found that psychotherapy and behavioral activation therapy can change blood biomarkers for depression, potentially leading to more precise treatment.